Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia ; volume:38 ; number:8 ; day:24 ; month:6 ; year:2024 ; pages:1712-1721 ; date:8.2024
Leukemia ; 38, Heft 8 (24.6.2024), 1712-1721, 8.2024
- Creator
-
Pozzo, Federico
Forestieri, Gabriela
Vit, Filippo
Ianna, Giulia
Tissino, Erika
Bittolo, Tamara
Papotti, Robel
Gaglio, Annalisa
Terzi di Bergamo, Lodovico
Steffan, Agostino
Polesel, Jerry
Bulian, Pietro
Laureana, Roberta
Tafuri, Agostino
Chiarenza, Annalisa
Di Raimondo, Francesco
Olivieri, Jacopo
Zaja, Francesco
Laurenti, Luca
Del Principe, Maria Ilaria
Postorino, Massimiliano
Del Poeta, Giovanni
Bomben, Riccardo
Zucchetto, Antonella
Rossi, Davide
Gattei, Valter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-024-02301-y
- URN
-
urn:nbn:de:101:1-2410132108597.374124962792
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pozzo, Federico
- Forestieri, Gabriela
- Vit, Filippo
- Ianna, Giulia
- Tissino, Erika
- Bittolo, Tamara
- Papotti, Robel
- Gaglio, Annalisa
- Terzi di Bergamo, Lodovico
- Steffan, Agostino
- Polesel, Jerry
- Bulian, Pietro
- Laureana, Roberta
- Tafuri, Agostino
- Chiarenza, Annalisa
- Di Raimondo, Francesco
- Olivieri, Jacopo
- Zaja, Francesco
- Laurenti, Luca
- Del Principe, Maria Ilaria
- Postorino, Massimiliano
- Del Poeta, Giovanni
- Bomben, Riccardo
- Zucchetto, Antonella
- Rossi, Davide
- Gattei, Valter
- SpringerLink (Online service)
Other Objects (12)
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Ibrutinib for improved chimeric antigen receptor T cell production for chronic lymphocytic leukemia patients
Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib
Functional analysis of phospholipase C-γ2 mutants conferring ibrutinib resistance to chronic lymphocytic leukemia cells
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL
Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Ibrutinib for improved chimeric antigen receptor T cell production for chronic lymphocytic leukemia patients
Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib
Functional analysis of phospholipase C-γ2 mutants conferring ibrutinib resistance to chronic lymphocytic leukemia cells
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL
Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Ibrutinib for improved chimeric antigen receptor T cell production for chronic lymphocytic leukemia patients
Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib
Functional analysis of phospholipase C-γ2 mutants conferring ibrutinib resistance to chronic lymphocytic leukemia cells
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL